维普中文期刊产品整合服务
28篇 您的检索式:作者名="Topol SE"
    题名 作者 年代 出处 被引量
1Mutation of MEF2Ain an inherited disorder with features of coronary artery disease显示文摘Wang Q Fan C Topol SE 2003Science2003,302,5650:1
2Mutation of MEF2A in an inherited disorder with the features of coronary artery disease显示文摘Wang L Fan C Topol SE 2003Science2003,302,5650:1
3Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus显示文摘Nissen SE Wolski K Topol EJ 2005JAMA2005,294,:1
4Mutation of MEF2A in an inherited disorder with features of coronary artery disease显示文摘Wang L Fan C Topol SE 2003Science2003,302,5650:1
5Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus显示文摘Nissen SE Wolski K Topol EJ 2005JAMA2005,294,20:1
6Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus显示文摘Nissen SE Wolski K Topol EJ 0,,:1
7Our preoccupation with coronary luminology:the dissociation between clinical and angiographic findings in ischemic heart disease显示文摘 Nissen SE 1995Circulation1995,92,:1
8Risk of cardiovascular events associated with selective COX-2 inhibitors显示文摘Mukherjee D Nissen SE Topol EJ 2001JAMA2001,286,:1
9Risk of cardiovascular events ass,ciated with selective COX - 2 inhibitors显示文摘Mukherjee D Nissen SE Topol EJ 0,,:1
10Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus显示文摘 Wolski K Topol EJ 2005JAMA2005,294,:1
11Mutation of MEF2A in an inheri-ted disorder with features of coronary artery disease 显示文摘Wang L Fan C Topol SE 2003Science2003,302,2650:1
12Mutation of MEF2A in an inherited disorder with features of coronary artery disease显示文摘 Fan C Topol SE 2003Science2003,302,5650:1
13Mutation of MEF2A in an inherited disorder with features of coronary artery disease 显示文摘Wang L Fan C Topol SE 2003Science2003,302,:1
14Mutation of MEF2A in an inherited disorder with features of coronary artery disease 显示文摘Wang L Fan C Topol SE 2003Science2003,302,:1
15Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus 显示文摘Nissen SE Wolski K Topol EJ 2005JAMA2005,294,20:1
16Risk of cardiovascular events associated with selective COX-2 inhibitors显示文摘Mukerjee D Nissen SE Topol EJ 2001JAMA2001,286,:1
17Our preoccupation with coronary Iuminology:The dissociation betwesn clinical and angiographic findings in ischemic heart disease显示文摘Topol EJ Nissen SE 1995Circulation1995,92,8:1
18Risk of cardiovascular events associated with selective COX-2 inhibitors 显示文摘Mukherjee D Nissen SE Topol EJ 2001JAMA2001,286,8:1
19Effect of muraglitazar on death and major adverse cardiovascuXar events in patients with type 2 diabetes mellitus 显示文摘NISSEN SE WOLSKI K TOPOL EJ 2005JAMA2005,294,20:1
20Our preoccupation with coronary luminology , the dissociation between clinical and angiographic findings in ischemic heart disease 显示文摘Topol El Nissen SE 1995Circulation1995,92,8:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费